乳腺的侵入性乳头癌的乳头癌
Shijing Wang1, Qingfu Zhang2, Xiaoyun Mao1
1Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Frontiers in oncology
|April 11, 2024
概括
侵袭性乳头癌是绝经后妇女罕见的乳腺癌,由于转移率低,预后有利. 需要使用有机体和基因分析进行进一步的研究,以确定最佳的治疗策略.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 侵袭性乳头癌是一种罕见的乳腺癌亚型,主要影响绝经后妇女.
- 有限的研究,主要是病例报告和小型回顾性研究,阻碍了理解和临床管理.
- 这种瘤类型具有独特的病理特征和生物行为.
研究的目的:
- 审查目前对侵袭性乳头癌的理解.
- 为了突出需要先进的研究方法,由于这种情况的稀有性.
- 强调分子洞察力对治疗决策的潜力.
主要方法:
- 现有案例报告和回顾性研究的文献综述.
- 讨论病理和生物特征.
- 探索潜在的研究途径,包括有机体模型和基因表达造型.
主要成果:
- 侵入性乳头癌通常是光线类型,淋巴结转移率低,这表明预后有利.
- 对这种特定癌症类型的辅助疗法的疗效尚不清楚.
- 侵入性乳头癌的罕见性使得未来的临床试验具有挑战性.
结论:
- 器官模型和全面的基因表达造型对于推进研究和理解侵袭性乳头癌至关重要.
- 进一步的分子水平的研究是必要的,以优化患者的治疗策略.
- 需要改进的研究方法来克服这种乳腺癌亚型的稀有性所带来的挑战.
更多相关视频
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


